Background and Purpose:
The neurocognitive benefits of donepezil are well recognised, but the
potential side effects on cardiac conduction remain unclear. Our
objectives are to investigate whether long-term donepezil therapy is
associated with electrocardiographic (ECG) changes and in particular to
assess its effects on the QT interval.